Kendra Adams
Director Financiero/CFO en C4 THERAPEUTICS, INC. .
Fortuna: 410 195 $ al 31/05/2024
Perfil
Kendra R.
Adams is currently the Chief Financial Officer & Treasurer at C4 Therapeutics, Inc. She previously worked as the Director-Investor Relations at ARIAD Pharmaceuticals, Inc. and as the VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc. Ms. Adams completed her undergraduate degree at Hamilton College (New York).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.12% | 07/03/2024 | 82 039 ( 0.12% ) | 410 195 $ | 31/05/2024 |
Cargos activos de Kendra Adams
| Empresas | Cargo | Inicio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director Financiero/CFO | 18/09/2023 |
Antiguos cargos conocidos de Kendra Adams.
| Empresas | Cargo | Fin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | - |
| ARIAD PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | - |
Formación de Kendra Adams.
| Hamilton College (New York) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kendra Adams
